Antimicrobial resistance is a global health issue contributing significantly to patient mortality and rising healthcare costs across the world. There is a clear need to quickly and accurately identify the nature of a pathogen in order to define the most appropriate treatment strategy with the optimal clinical result. Nearly all significant bacterial infections in the world are becoming resistant to commonly used antibiotics.
The Test Target Treat™ initiative from Alere empowers you to make targeted treatment decisions sooner with rapid diagnostics, reducing inappropriate antimicrobial use and the spread of resistance.
Want to know more about how rapid diagnostics can contribute to Antimicrobial Stewardship? Visit TestTargetTreat.com today to discover a broad range of educational tools and information.